What topical antibiotic eye drops are recommended for treating presumed bacterial conjunctivitis in an otherwise healthy adult, including alternatives for sulfa or polymyxin allergy and for contact‑lens wearers?

Topical Antibiotic Eye Drops for Bacterial Conjunctivitis

First-Line Treatment for Mild Cases

For mild bacterial conjunctivitis in healthy adults, select any broad-spectrum topical antibiotic based on cost and convenience, as no specific agent demonstrates clinical superiority; treatment is optional since most cases self-resolve, but antibiotics shorten symptom duration by 2-5 days. 1

• Mild bacterial conjunctivitis typically resolves spontaneously without treatment in immunocompetent adults 1
• A 5- to 7-day course of any broad-spectrum topical antibiotic is usually effective 1
• Choose the most convenient or least expensive option - there is no clinical evidence suggesting superiority of any particular antibiotic 1
• Topical antibacterial therapy provides earlier clinical and microbiological remission compared with placebo during days 2-5 of treatment, with benefits persisting through days 6-10 1
• Antibiotics increase clinical cure by 26% compared to placebo (68.2% vs 55.5% spontaneous resolution) 2

Practical First-Line Options

• Polymyxin B/trimethoprim: Traditional, inexpensive option dosed four times daily 3
• Fluoroquinolones (moxifloxacin 0.5%, besifloxacin 0.6%, ofloxacin 0.3%): Dosed three times daily with broader coverage 4, 3, 5
• Povidone-iodine 1.25% ophthalmic solution: May be as effective as topical antibiotics when access is limited 1

Moderate to Severe Cases

For moderate to severe bacterial conjunctivitis with copious purulent discharge, pain, and marked inflammation, obtain conjunctival cultures and Gram stain before starting empiric broad-spectrum antibiotics. 1

• Characterized by copious purulent discharge, pain, and marked inflammation 1
• Obtain cultures and Gram stain if gonococcal infection is suspected 1
• Consider MRSA coverage, as methicillin-resistant S. aureus is increasingly isolated from bacterial conjunctivitis and is resistant to many commercially available topical antibiotics 1
• Microbiology testing may guide therapy, potentially requiring compounded topical vancomycin 1

Contact Lens Wearers

Contact lens wearers with bacterial conjunctivitis require mandatory antibiotic treatment with fluoroquinolones to cover Pseudomonas aeruginosa, as these cases should never be observed without treatment. 6

• Conjunctivitis in contact lens wearers must be treated with antibiotics due to risk of Pseudomonas infection 6
• Fluoroquinolones provide the necessary Pseudomonas coverage 4, 5
• Moxifloxacin demonstrated superior efficacy compared to polymyxin B/trimethoprim, with 81% complete resolution at 48 hours versus 44% 3

Allergy Considerations

Sulfa Allergy

• Use fluoroquinolones (moxifloxacin, besifloxacin, ofloxacin, ciprofloxacin) - these are not sulfonamides and are safe 4, 3, 5
• Aminoglycosides (gentamicin, tobramycin, netilmicin) are also safe alternatives 7, 8

Polymyxin Allergy

• Avoid polymyxin B/trimethoprim combination 3
• Use fluoroquinolones as first alternative - moxifloxacin, besifloxacin, or ofloxacin 4, 3
• Aminoglycosides (gentamicin, tobramycin) are additional options 7, 8
• Note: Significant bacterial resistance exists against polymyxin B (24%), neomycin (16%), and bacitracin (9%) 5

Specific Antibiotic Performance

Fluoroquinolones (Preferred Class)

• Moxifloxacin 0.5%: Three times daily dosing, identified as best commercially available antibiotic with 93-98% bacterial sensitivity 5
• Besifloxacin 0.6%: Three times daily for 7 days, noninferior to moxifloxacin with 58.3% clinical resolution and 93.3% microbial eradication 4
• Ofloxacin 0.3%: Achieves 2.4-fold greater aqueous humor concentration than trimethoprim (1.135 vs 0.470 μg/mL) 9
• Fluoroquinolones result in fewer ocular side effects compared to non-fluoroquinolones 2

Non-Fluoroquinolone Options

• Polymyxin B/trimethoprim: Four times daily, slower resolution (44% at 48 hours) but less expensive 3
• Aminoglycosides: Netilmicin showed 96.9% bacterial sensitivity versus 75% for gentamicin 8

Critical Pitfalls

• Never use topical antibiotics alone for gonococcal conjunctivitis - systemic antibiotic therapy is mandatory 1
• Do not assume all mattering indicates bacterial infection - mattering, lack of itching, and no history of conjunctivitis are strongest bacterial predictors, but viral conjunctivitis can present variably 6
• Avoid gentamicin in neonatal settings - gram-negative conjunctivitis in low birth weight infants is often gentamicin-resistant 1
• MRSA isolates are resistant to many commercially available topical antibiotics and may require compounded vancomycin 1

Follow-Up Recommendations

• Advise patients to return in 3-4 days if no improvement noted 1
• Treatment reduces transmissibility and allows earlier return to work or school 1
• Antibiotics reduce risk of persistent clinical infection by 27% (RR 0.73) 2